Ecron and Newcastle University agree clinical trials partnership

By Michael Stones

- Last updated on GMT

Related tags Clinical trial

India-based CRO Ecron Acunova has agreed a clinical research partnership with the UK’s Newcastle University.

Building on initial discussions, both parties recently signed a memorandum of understanding to work together on clinical trials.

To launch the new working relationships Ecron Acunova has contracted a first clinical research study at Newcastle University.


The company plans to expand its operations in the UK and reports that it views the new partnership as a good launch-pad to achieve this goal.

With European headquarters in Frankfurt, Ecron Acunova provides services for phase I - IV clinical research, including clinical trial management, clinical data management, PK/PD services and central lab for pharmaceutical, biotech, nutritional, medical diagnostic and device sponsors.

Newcastle University is a member of the Russell Group, an association of research-intensive UK universities.

Meanwhile last month, Ecron Acunova forged a partnership with Chulalongkorn University, Thailand to under take contract research.

Expand medical research

The partnership will expand medical research work in Thailand while creating new knowledge and academic work and developing the university's personnel and Thai research work system,”​ said Prof Kua Wongbunsin, the rector for research operations.

The newly Chula Clinical Research Centre will take on research work assigned to it by Ecron Acunova. A particular focus will be research in Southeast Asian countries.

Speaking last month, DA Prasanna, founder of Ecron Acunova CRO, said Southeast Asia was an important market for CRO, especially after leading pharmaceutical firms included the region in their areas of interest for medicine development.

Thailand stood out in a Princeton University study for CRO work among many countries including Malaysia and Singapore, he said.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more